Literature DB >> 9634715

[Sulfated polysaccharides as inhibitors of receptor activity of P-selectin and P-selectin-dependent inflammation].

A V Semenov1, A V Mazurov, M E Preobrazhenskaia, N A Ushakova, V I Mikhaĭlov, A E Berman, A I Usov, N E Nifant'ev, N V Bovin.   

Abstract

The inhibitory effects of sulfated polysaccharides-fucoidan and heparin on P-selectin-ligand interaction in vitro and on the ability of fucoidan to inhibit the leukocyte extravasation in rat peritonitis were studied. The lectin activity of P-selectin in vitro was based on its ability to bind lectin-labeled synthetic ligand, Sialyl-Lea/x, conjugated with polyacrylamide (PAA). Fucoidan and heparin inhibited binding of labeled ligand to both purified P-selectin and the activated platelets expressing P-selectin on their surface. The inhibitory effect of fucoidan 100-fold higher than that of heparin. As P-selectin plays an important role at an earlier stage of the inflammation process, the antiinflammatory action of fucoidan on P-selectin-dependent peritonitis in rats was studied. Peritonitis was induced by intraperitoneal injection of the peptone solution and was characterized by an increase in total cell number and neutrophil percentage in rat peritone exudate. Intravenous injection of fucoidan was found to cause a dose- and time-dependent reduction of neutrophil extravasation into inflamed peritoneum. The minimal dose of fucoidan, that was able to produce 96.8 +/- 2.9% inhibition of neutrophil extravasation--if administered within the first 15 min after peptone-B was 0.8 mg per rat. Significant effect of fucoidan injection (about 80% inhibition) was also obtained 1.5 h after the induction of inflammation. Fucoidan administered 2.5 h after peptone had virtually no effect on neutrophil extravasation. The data obtained show that fucoidan blocks the inflammation process at its earlier stages--most probably at the expense of its interaction with P-selectin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9634715

Source DB:  PubMed          Journal:  Vopr Med Khim        ISSN: 0042-8809


  6 in total

Review 1.  Important determinants for fucoidan bioactivity: a critical review of structure-function relations and extraction methods for fucose-containing sulfated polysaccharides from brown seaweeds.

Authors:  Marcel Tutor Ale; Jørn D Mikkelsen; Anne S Meyer
Journal:  Mar Drugs       Date:  2011-10-24       Impact factor: 6.085

2.  Prophylactic administration of fucoidan represses cancer metastasis by inhibiting vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in Lewis tumor-bearing mice.

Authors:  Tse-Hung Huang; Yi-Han Chiu; Yi-Lin Chan; Ya-Huang Chiu; Hang Wang; Kuo-Chin Huang; Tsung-Lin Li; Kuang-Hung Hsu; Chang-Jer Wu
Journal:  Mar Drugs       Date:  2015-04-03       Impact factor: 5.118

Review 3.  Hypopigmenting Effects of Brown Algae-Derived Phytochemicals: A Review on Molecular Mechanisms.

Authors:  Mohammed Shariful Azam; Jinkyung Choi; Min-Sup Lee; Hyeung-Rak Kim
Journal:  Mar Drugs       Date:  2017-09-24       Impact factor: 5.118

4.  Sphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism.

Authors:  Amanda Finley; Zhoumou Chen; Emanuela Esposito; Salvatore Cuzzocrea; Roger Sabbadini; Daniela Salvemini
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

Review 5.  Extracts and Marine Algae Polysaccharides in Therapy and Prevention of Inflammatory Diseases of the Intestine.

Authors:  Natalya N Besednova; Tatyana S Zaporozhets; Tatyana A Kuznetsova; Ilona D Makarenkova; Sergey P Kryzhanovsky; Lydmila N Fedyanina; Svetlana P Ermakova
Journal:  Mar Drugs       Date:  2020-05-31       Impact factor: 5.118

6.  Anti-Inflammatory Activity of Fucoidan Extracts In Vitro.

Authors:  Tauseef Ahmad; Mathew Suji Eapen; Muhammad Ishaq; Ah Young Park; Samuel S Karpiniec; Damien N Stringer; Sukhwinder Singh Sohal; J Helen Fitton; Nuri Guven; Vanni Caruso; Rajaraman Eri
Journal:  Mar Drugs       Date:  2021-12-11       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.